SLC2A1 and rheumatoid arthritis: The AKT/mTOR pathway has previously been shown to control glucose uptake and metabolism; therefore, we examined glucose transporter 1 (GLUT1) expression in RA patient PD-1+ and PD-1– B cells (22, 23).